
Citation: Javier Fernández, Sául Redondo-Blanco, Elisa M. Miguélez, Claudio J. Villar, Alfonso Clemente, Felipe Lombó. Healthy effects of prebiotics and their metabolites against intestinal diseases and colorectal cancer[J]. AIMS Microbiology, 2015, 1(1): 48-71. doi: 10.3934/microbiol.2015.1.48
[1] | Fang Wang, Lianying Cao, Xiaoji Song . Mathematical modeling of mutated COVID-19 transmission with quarantine, isolation and vaccination. Mathematical Biosciences and Engineering, 2022, 19(8): 8035-8056. doi: 10.3934/mbe.2022376 |
[2] | Fernando Saldaña, Hugo Flores-Arguedas, José Ariel Camacho-Gutiérrez, Ignacio Barradas . Modeling the transmission dynamics and the impact of the control interventions for the COVID-19 epidemic outbreak. Mathematical Biosciences and Engineering, 2020, 17(4): 4165-4183. doi: 10.3934/mbe.2020231 |
[3] | Maryam Al-Yahyai, Fatma Al-Musalhi, Ibrahim Elmojtaba, Nasser Al-Salti . Mathematical analysis of a COVID-19 model with different types of quarantine and isolation. Mathematical Biosciences and Engineering, 2023, 20(1): 1344-1375. doi: 10.3934/mbe.2023061 |
[4] | Shina D. Oloniiju, Olumuyiwa Otegbeye, Absalom E. Ezugwu . Investigating the impact of vaccination and non-pharmaceutical measures in curbing COVID-19 spread: A South Africa perspective. Mathematical Biosciences and Engineering, 2022, 19(1): 1058-1077. doi: 10.3934/mbe.2022049 |
[5] | Qinghua Liu, Siyu Yuan, Xinsheng Wang . A SEIARQ model combine with Logistic to predict COVID-19 within small-world networks. Mathematical Biosciences and Engineering, 2023, 20(2): 4006-4017. doi: 10.3934/mbe.2023187 |
[6] | Jingjing Tian, Jiabing Wu, Yunting Bao, Xiaoyu Weng, Lei Shi, Binbin Liu, Xinya Yu, Longxing Qi, Zhirong Liu . Modeling analysis of COVID-19 based on morbidity data in Anhui, China. Mathematical Biosciences and Engineering, 2020, 17(4): 2842-2852. doi: 10.3934/mbe.2020158 |
[7] | Rong Yuan, Yangjun Ma, Congcong Shen, Jinqing Zhao, Xiaofeng Luo, Maoxing Liu . Global dynamics of COVID-19 epidemic model with recessive infection and isolation. Mathematical Biosciences and Engineering, 2021, 18(2): 1833-1844. doi: 10.3934/mbe.2021095 |
[8] | Yuto Omae, Yohei Kakimoto, Jun Toyotani, Kazuyuki Hara, Yasuhiro Gon, Hirotaka Takahashi . SIR model-based verification of effect of COVID-19 Contact-Confirming Application (COCOA) on reducing infectors in Japan. Mathematical Biosciences and Engineering, 2021, 18(5): 6506-6526. doi: 10.3934/mbe.2021323 |
[9] | Liping Wang, Jing Wang, Hongyong Zhao, Yangyang Shi, Kai Wang, Peng Wu, Lei Shi . Modelling and assessing the effects of medical resources on transmission of novel coronavirus (COVID-19) in Wuhan, China. Mathematical Biosciences and Engineering, 2020, 17(4): 2936-2949. doi: 10.3934/mbe.2020165 |
[10] | C. K. Mahadhika, Dipo Aldila . A deterministic transmission model for analytics-driven optimization of COVID-19 post-pandemic vaccination and quarantine strategies. Mathematical Biosciences and Engineering, 2024, 21(4): 4956-4988. doi: 10.3934/mbe.2024219 |
The COVID-19 pandemic has spread globally since 2019, and it has been threatening the public health, economy and social life of all human beings, which is regarded as an unprecedented public crisis and challenge. As of 26 August 2021, over 213, 752, 662 infected cases have been reported with 4, 459, 381 deaths [1]. Non-pharmaceutical interventions (NPIs), such as personal protective measures (social distancing, hand washing, mask wearing, etc.), environmental measures (disinfecting and sterilizing), surveillance measures (large-scale screening, contact tracing, home quarantine, isolation, etc.), domestic and international travel restrictions, have been strictly implemented worldwide, and a mass vaccination program against COVID-19 has been actively promoted, to suppress SARS-CoV-2 transmission and reduce the mortality and morbidity of COVID-19. However, the situation remains severe and uncertain, in particular with the emerging of novel SARS-CoV-2 variants which may be more transmissible than the ancestral lineage first identified [2].
In China, the epidemic situation was almost under control with the strict NPIs and mass vaccination. However, imported cases from abroad, especially from high-risk regions, have occasionally caused several epidemic outbreaks in some cities [3,4,5,6]. For example, on 21 May 2021, a local confirmed case of COVID-19 from Liwan District, Guangzhou City, Guangdong Province was reported, causing a new round of infections, invoking concern [7]. The mutant strain (Delta variant, B.1.617.2) of the SARS-CoV-2 discovered in India spread into China for the first time during this outbreak [2,8], and it is 97% more transmissible than the original strain [9]. The higher transmissibility and shorter incubation period of the Delta variant [2,8,10,11,12] has introduced new challenges to the control of the outbreak.
Because of the experience of containing the COVID-19 outbreaks, the Guangzhou New Coronavirus Pneumonia Epidemic Prevention and Control Headquarters responded quickly to stop COVID-19 spread and protect the health and safety of the public [13]. Close contact tracing was immediately carried out, the traced contacts were quarantined centrally in dedicated accommodation such as hotels or quarantine centers, nucleic acid testing were performed during their quarantine period, and access to the regions where the infected cases had visited was restricted [14]. Simultaneously, multiple rounds of nucleic acid testing were performed in the closed management areas. Furthermore, the prevention and control of the epidemic were strengthened and the nucleic acid testing and screening of personnel were extended for all residents and temporary residents in the whole city. Several areas, including Baihedong Street, Zhongnan Street, Hailong Street, Dongjiao Street, Chongkou Street in Liwan District, Ruibao Street and Shayuan Street in Haizhu District, and Luopu Street in Panyu District were adjusted to closed management areas and were locked down successively from 29 May 2021, according to Announcement No. 13 of the Municipal Epidemic Prevention and Control Headquarters [15]. The compulsory home quarantine measure was implemented in closed management areas and people in these communities were required to stay at home. With the timely implementation of prevention and control measures and the active cooperation of the people in Guangzhou, the epidemic in Guangzhou was effectively curbed, and the closure and containment management measures were lifted successively. On 26 June, all medium risk areas in Guangzhou were cleared, and on the morning of 8 July, hospitalized cases were all recovered and cleared [16].
Quarantine measures including both the centralized quarantine by close contact tracing and the compulsory home quarantine measure, which is one of the most widely used NPIs [17,18] in the containment of COVID-19 in China, were implemented for the prevention and control of the epidemic in Guangzhou. However, despite the effectiveness of these two quarantine measures, the centralized quarantine measure is always very expensive since the traced close contacts would be isolated completely in dedicated accommodation such as hotels or quarantine centers and so is limited by resource restrictions, while though home quarantine may conserve resources, cross-infection and transmission within family households may occur [19,20,21], which may make the situation worse. Consequently, it is unclear how these two quarantine measures combine to contain COVID-19. Thus, in this study, by taking the epidemic in Guangzhou city in 2021 as an example, we aim to establish a stochastic discrete model to evaluate the effectiveness of the centralized quarantine and the home quarantine measures. Finding a balanced combination between them would be of considerable importance, providing policymakers with useful information for decisions of whether and when to implement the compulsory home quarantine measure.
The rest of this paper is organized as follows. The stochastic discrete model incorporating the two quarantine measures and cross-infection within family households is established and the data sets we used and parameter estimation methods are introduced in Section 2. The estimation results and sensitivity analysis of the impact of the quarantine rates and implementation timing of compulsory home quarantine are illustrated in Section 3. The discussion and conclusion are given in Sections 4 and 5.
Based on the transmission mechanism of COVID-19, the epidemiological status of individuals and the prevention and control measures implemented in Guangzhou city, we propose a discrete-time stochastic model [22,23,24] incorporating home quarantine, close contact tracing and centralized quarantine measures. The flow diagram of the transmission dynamics is presented in Figure 1. To clearly illustrate the model dynamic, we describe a deterministic version of the model in differential equations [25,26,27], given in model (1), followed by the discrete stochastic model (2) in the analysis.
$ \left\{ \\ -\sigma {E}_{h}, \\ \frac{d{I}_{h}}{dt} = \sigma {E}_{h}-{\delta }_{{I}_{h}}{I}_{h}, \\ \end{array}\end{array}\end{array}\end{array}\right. $
|
(1) |
The basic modelling framework for the transmission dynamics is an $ SEIHR $ model, in which the total population is divided into five classes: susceptible ($ S $), exposed ($ E $, people in this class are infected but not infectious), infectious ($ I $, including both symptomatic and asymptomatic infectives), hospitalized $ (H $), and recovered ($ R $). The population is further divided into three categories according to their quarantine states: not quarantined, home quarantined and centralized quarantined. Here, we use the subscripts 'h' and 'q' to represent home quarantine and centralized quarantine, respectively. Denote $ N = S+E+I $ and $ {Q}_{h} = {S}_{h}+{E}_{h}+{I}_{h} $. The transmission occurs when the susceptible (or home quarantined susceptible) population in class $ S $ (or $ {S}_{h} $) become close contacts of infectious (or home quarantined infectious) population in class $ I $ (or $ {I}_{h} $) with the contact rate $ {c}_{1} $ (or $ {c}_{2} $) and then become infected with transmission probability $ {\beta }_{1} $ (or $ {\beta }_{2} $) per contact. Assume that a proportion $ {q}_{1} $ (or $ {q}_{2} $) of the close contacts for unquarantined (or home quarantined) individuals will be traced and move to the centralized quarantined susceptible/exposed compartments ($ {S}_{q}/{E}_{q} $) if they are not infected/infected. The untraced population will stay in the susceptible (or home quarantined susceptible) class with proportion $ 1-{q}_{1} $ (or $ 1-{q}_{2} $) if they are not infected, or move to the exposed (or home quarantined exposed) class $ E $ (or $ {E}_{h} $) if they are infected with the transmission probability $ {\beta }_{1} $ (or $ {\beta }_{2} $) per contact. Individuals in $ E $ or $ {E}_{h} $ class will enter into the infectious ($ I $) or home quarantined infectious ($ {I}_{h} $) class with the transition rate $ \sigma $, where $ 1/\sigma $ is the incubation period. Note that population in compartment $ {E}_{q} $ are those who are carrying virus but would not transmit to others since people who are centralized quarantined have no contact with others, thus no infection or transmission occurs among them. While infection and transmission within family-households could not be ignored [28], and new infection may occur among home quarantined population, susceptible individuals in compartment $ {S}_{h} $ will be infected by infectious individuals in compartment $ {I}_{h} $. Further, infected individuals in compartments $ I, {E}_{q}, {I}_{h} $ would be diagnosed and isolated at rates $ {\delta }_{I}, {\delta }_{{E}_{q}}, {\delta }_{{I}_{h}} $ respectively, and individuals in $ I $ and $ H $ will be recovered at rate $ {\gamma }_{I}, {\gamma }_{H} $, respectively. Susceptible individuals are released from $ {S}_{q} $ to $ {S}_{h} $ and from $ {S}_{h} $ to $ S $ with the releasing rates $ {\lambda }_{1}, {\lambda }_{2} $, respectively. More detailed definition and values of variables and parameters are listed in Table 1.
Then we create a stochastic, time-discretized version of the model described above. Consider a time interval $ \left(t, t+\Delta t\right) $, where $ \Delta t $ represents the time between two discrete time points, here $ \Delta t = 1 $ day. Because of the randomness of the disease infection and transmission, we assume that the flow between any two compartments is a stochastic process and the length of time that an individual spends in a compartment is exponentially distributed [23]. Let $ {D}_{ij}\left(t\right) $ denote the number of individuals transferred out of compartment $ i $, where $ i = 1, \mathrm{ }2, \dots, \mathrm{ }9 $ represent the compartments $ S, E, I, {S}_{q}, {E}_{q}, {S}_{h}, {E}_{h}, {I}_{h}, H $, respectively. The detailed descriptions of $ {D}_{ij}\left(t\right) $ are given as follows:
• $ {D}_{11}\left(t\right) $ is the number of newly infected individuals in unquarantined population;
• $ {D}_{12}\left(t\right) $ is the number of newly centralized quarantined individuals who are close contacts but not infected in unquarantined population;
• $ {D}_{21}\left(t\right) $ is the number of individuals transferred from exposed to infectious in unquarantined population;
• $ {D}_{31}\left(t\right) $ is the number of newly reported cases diagnosed from unquarantined infectious population;
• $ {D}_{32}\left(t\right) $ is the number of newly recovered individuals from unquarantined infectious individuals;
• $ {D}_{41}\left(t\right) $ is the number of susceptible individuals released from centralized quarantine to home quarantine;
• $ {D}_{51}\left(t\right) $ is the number of newly reported cases diagnosed from the centralized quarantined infected individuals;
• $ {D}_{61}\left(t\right) $ is the number of newly infected individuals in home quarantined population;
• $ {D}_{62}\left(t\right) $ is the number of newly centralized quarantined individuals who were close contacts but not infected in home quarantined population;
• $ {D}_{63}\left(t\right) $ is the number of susceptible individuals released from home quarantine;
• $ {D}_{71}\left(t\right) $ is the number of individuals transferred from exposed to infectious in home quarantined population;
• $ {D}_{81}\left(t\right) $ is the number of newly reported cases diagnosed from home quarantined infectious individuals;
• $ {D}_{91}\left(t\right) $ is the number of newly recovered cases from hospitalized individuals.
We have to emphasize that the compulsory home quarantine measure is implemented in closed management areas, here we assume it is implemented only once at the specific day with a fraction ($ {p}_{S}, {p}_{E}, {p}_{I} $) of individuals in unquarantined susceptible ($ S $), exposed ($ E $), infectious class ($ I $) moving into the home quarantined susceptible ($ {S}_{h}) $, exposed ($ {E}_{h} $), infectious class $ \left({I}_{h}\right) $, respectively. Then the corresponding stochastic discrete-time model is specified by the following model:
$ \left\{ \right. $
|
(2) |
with
$ {P}_{S}\left(t\right) = \left\{ \right. {P}_{E}\left(t\right) = \left\{ \right. {P}_{I}\left(t\right) = \left\{ \right. $
|
Here, $ T $ is the corresponding time when the compulsory home quarantine strategy was implemented, and $ {P}_{S}\left(t\right), {P}_{E}\left(t\right), {P}_{I}\left(t\right) $ are the proportions of unquarantined susceptible, exposed, infected individuals moved to the corresponding class home quarantined, respectively. Note that, for simplicity, we assume that the closed management areas were all announced on the morning of 29 May.
In model (2), $ {D}_{ij}\left(t\right) $ are random variables with binomial distributions with probabilities $ {P}_{ij}\left(t\right) $ :
$ {D}_{11}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left(S\left(t\right), {P}_{11}\left(t\right)\right), {D}_{12}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left(S\left(t\right), {P}_{12}\left(t\right)\right), {D}_{21}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left(E\left(t\right), {P}_{21}\left(t\right)\right), $ |
$ {D}_{31}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left(I\left(t\right), {P}_{31}\left(t\right)\right), {D}_{32}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left(I\left(t\right), {P}_{32}\left(t\right)\right), {D}_{41}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left({S}_{q}\left(t\right), {P}_{41}\left(t\right)\right), $ |
$ {D}_{51}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left({E}_{q}\left(t\right), {P}_{51}\left(t\right)\right), {D}_{61}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left({S}_{h}\left(t\right), {P}_{61}\left(t\right)\right), {D}_{62}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left({S}_{\mathrm{h}}\left(t\right), {P}_{62}\left(t\right)\right), $ |
$ {D}_{63}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left({S}_{h}\left(t\right), {P}_{63}\left(t\right)\right), {D}_{71}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left({E}_{h}\left(t\right), {P}_{71}\left(t\right)\right), {D}_{81}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left({I}_{\mathrm{h}}\left(t\right), {P}_{81}\left(t\right)\right), $ |
$ {D}_{91}\left(t\right) \sim \mathrm{B}\mathrm{i}\mathrm{n}\left(H\left(t\right), {P}_{91}\left(t\right)\right), $ |
where
$ {P}_{11}\left(t\right) = 1-\mathrm{exp}\left(-\frac{{c}_{1}{\beta }_{1}I}{N}\Delta t\right), {P}_{12}\left(t\right) = 1-\mathrm{exp}\left(-\frac{{c}_{1}{q}_{1}\left(1-{\beta }_{1}\right)I}{N}\Delta t\right), $ |
$ {P}_{21}\left(t\right) = 1-\mathrm{exp}\left(-\sigma \Delta t\right), {P}_{31}\left(t\right) = 1-\mathrm{exp}\left(-{\delta }_{I}\Delta t\right), {P}_{32}\left(t\right) = 1-\mathrm{exp}\left(-{\gamma }_{I}\Delta t\right), $ |
$ {P}_{41}\left(t\right) = 1-\mathrm{exp}\left(-{\lambda }_{1}\Delta t\right), {P}_{51}\left(t\right) = 1-\mathrm{exp}\left(-{\delta }_{{E}_{q}}\Delta t\right), $ |
$ {P}_{61}\left(t\right) = 1-\mathrm{exp}\left(-\frac{{c}_{2}{\beta }_{2}{I}_{h}}{{Q}_{h}}\Delta t\right), {P}_{62}\left(t\right) = 1-\mathrm{exp}\left(-\frac{{c}_{2}{q}_{2}\left(1-{\beta }_{2}\right){I}_{h}}{{Q}_{h}}\Delta t\right), $ |
$ {P}_{63}\left(t\right) = 1-\mathrm{exp}\left(-{\lambda }_{2}\Delta t\right), {P}_{71}\left(t\right) = {P}_{21}\left(t\right), $ |
$ {P}_{81}\left(t\right) = 1-\mathrm{exp}\left(-{\delta }_{{I}_{h}}\Delta t\right), {P}_{91}\left(t\right) = 1-\mathrm{exp}\left(-{\gamma }_{H}\Delta t\right). $ |
We collect the epidemic data of COVID-19 in Guangzhou city from the Guangzhou Municipal Health Commission [29] and the People's Government of Guangzhou Municipality [13]. The data include the number of newly reported confirmed cases, the number of newly reported asymptomatic cases (see dark blue and light blue bars in Figure 2). Furthermore, by tracing to the source, we notice that some of the newly reported cases (including both the confirmed and asymptomatic cases) diagnosed from centralized quarantined population, were the close contacts of a previously announced infected case. Thus, we obtain the daily number of newly quarantined exposed individuals (see green bars in Figure 2). And we also obtain the quarantine time and the admission time to calculate the average period of an infected individual being centralized quarantined.
To compare the two epidemics of Guangzhou in 2020 and 2021, we also collect the daily reported cases from 21 January 21 to 24 February 2020 in Guangzhou, as shown in Figure 2 (orange bars).
To calibrate the model, we use the epidemic data of COVID-19 from 21 May to 20 June 2021 in Guangzhou city to estimate the unknown parameters. Firstly, by reviewing literatures, we fix some parameter values and the initial values of the variables to be constants, as listed in Table 1. In particular, the periods for cases remaining in both the centralized quarantine and home quarantine are 14 days [25,26], thus $ {\lambda }_{1} = {\lambda }_{2} = \frac{1}{14} $. The incubation period of the Delta variant is 4.4 days [8,31], thus $ \sigma = \frac{1}{4.4} $. Furthermore, from the real data, we find that the duration for an infected individuals being centralized quarantined is 4.07 days, thus $ {\delta }_{{E}_{q}} = \frac{1}{4.07} $. May 21 is set to be the initial time and $ \mathrm{S}\left(0\right) $ is set as the number of residents in Guangzhou, which is about 15, 300, 000 [32]. Note that eight areas with about 470, 750 residents in total were assigned to be closed management areas, and the compulsory home quarantine strategy was implemented at the beginning of 29 May 2021 (i.e., the end of the 8th day) [15], thus $ T = 8 $ and $ {p}_{S} = 0.0316 $. Since infected cases has not been reported at the beginning of 21 May, there were no home quarantined or centrally quarantined individuals, thus $ {S}_{q}\left(0\right) = 0, {E}_{q}\left(0\right) = 0, {S}_{h}\left(0\right) = 0, {E}_{h}\left(0\right) = 0, {I}_{h}\left(0\right) = 0, H\left(0\right) = 0, R\left(0\right) = 0 $.
Then by using the least square method, we fit model (2) with the number of newly reported cases, the number of newly infected cases being traced and centralized quarantined, and the accumulative number of reported cases from 21 May to 20 June in Guangzhou, and consequently estimate the values of unknown parameters, as shown in Table 1.
Variables | Description (Person) | Initial value | Resource |
mean (95%CI) | |||
$ S $ | Susceptible population unquarantined | 15, 300, 000 | [32] |
$ E $ | Exposed population unquarantined | 8.6602 (8.6358-8.6846) | Estimated |
$ I $ | Infectious population unquarantined | 3.9827 (3.9787-3.9867) | Estimated |
$ {S}_{q} $ | Centralized quarantined susceptible population | 0 | Data |
$ {E}_{q} $ | Centralized quarantined infected population | 0 | Data |
$ {S}_{h} $ | Home quarantined susceptible population | 0 | Data |
$ {E}_{h} $ | Home quarantined exposed population | 0 | Data |
$ {I}_{h} $ | Home quarantined infectious population | 0 | Data |
$ H $ | Hospitalized population | 0 | Data |
$ R $ | Recovered population | 0 | Data |
Parameters | Description | Value | Resource |
mean (95%CI) | |||
$ {c}_{1} $ | Contact rate among unquarantined population (per person per day) | 10.8614 (10.8348-10.8880) |
Estimated |
$ {\beta }_{1} $ | Transmission probability per contact among unquarantined population | 0.2538 (0.2523-0.2553) | Estimated |
$ {q}_{1} $ | Quarantine proportion of close contacts for individuals unquarantined | 0.1719 (0.1693-0.1744) | Estimated |
$ \sigma $ | Progression rate from exposed to infectious (per day) | 1/4.4 | [8,31] |
$ {\delta }_{I} $ | Diagnosis rate of infectious individuals unquarantined (per day) | 0.4633 (0.4604-0.4661) | Estimated |
$ {\gamma }_{I} $ | Recovery rate of unquarantined infectious individuals (per day) | 0.3417 (0.3275-0.3559) | Estimated |
$ {\lambda }_{1} $ | Releasing rate of susceptible individuals from centralized quarantine to home quarantine (per day) | 1/14 | [25,26] |
$ {\lambda }_{2} $ | Releasing rate of susceptible individuals from home quarantine (per day) | 1/14 | [25,26] |
$ {\delta }_{{E}_{q}} $ | Diagnosis rate of centralized quarantined infected individuals (per day) | 1/4.0745 | Data |
$ {c}_{2} $ | Contact rate among home quarantined population (per person per day) | 2.9966 (2.9947-2.9984) | Estimated |
$ {\beta }_{2} $ | Transmission probability per contact among home quarantined population | 0.2518 (0.2496-0.2540) | Estimated |
$ {q}_{2} $ | Quarantine proportion of close contacts for home quarantined individuals | 0.9277 (0.9254-0.9301) | Estimated |
$ {\delta }_{{I}_{h}} $ | Diagnosis rate of home quarantined infectious individuals (per day) | 0.5184 (0.5085-0.5284) | Estimated |
$ {\gamma }_{H} $ | Recovery rate of hospitalized individuals (per day) | 0.2640 (0.2563-0.2716) | Estimated |
$ {p}_{s} $ | Proportion of susceptible individuals being home quarantined | 0.0316 | Data |
$ {p}_{E} $ | Proportion of exposed individuals being home quarantined | 0.9995 (0.9994-0.9997) | Estimated |
$ {p}_{I} $ | Proportion of infectious individuals being home quarantined | 0.9844 (0.9834-0.9854) | Estimated |
We estimate the exponential growth rate of the daily reported cases and the effective reproduction number of the epidemic in Guangzhou in 2020 and 2021, respectively, to compare the two epidemics with different variants of SARS-CoV-2 in Guangzhou.
The basic reproduction number is calculated by using the formula $ {R}_{0} = \frac{1}{{\int }_{a = 0}^{\infty }{e}^{-ra}~~~g\left(a\right)da} $, where $ r $ is the corresponding exponential growth rate and $ g\left(a\right) $ is the generation interval distribution. Here the generation interval distribution was assumed to follow a Gamma distribution with mean 3.95 days and standard deviation 1.51 days in 2020 [36], and with mean 2.9 days and standard deviation 1.9 days in 2021 [8].
To estimate the effective reproduction number, let $ {M}_{t} $ be the number of newly reported cases on day $ t $, which is assumed to follow a Poisson distribution, and $ {g}_{\tau } $ be the discretized serial interval distribution which is assumed to follow a Gamma distribution with mean 3.95 days and standard deviation 4.24 days in 2020 [36], and with mean 2.3 days and standard deviation 3.4 days in 2021 [8]. Then with the renewal equation $ \mathrm{E}\left({M}_{t}\right) = {R}_{t}\sum _{\tau = 1}^{t}{g}_{\tau }{M}_{t-\tau } $, where $ \mathrm{E}(·) $ represents the expectation of a random variable, we can estimate the effective reproduction number $ {R}_{t} $ by applying a Bayesian method [34,35]. Assume that $ {R}_{t} $ is constant in the time interval $ [t-{t}_{1}+1, t] $ for $ t\ge {t}_{1} $, here we choose a time window with $ {t}_{1} = 5 $, and the prior distribution of $ {R}_{t} $ is a Gamma distribution with shape parameter $ a = 1 $ and scale parameter $ b = 5 $. Then the posterior distribution of $ {R}_{t} $ is a Gamma distribution with shape parameter and scale parameter being $ \mathrm{a}+\sum _{s = t-{t}_{1}+1}^{t}{M}_{s} $ and $ {(\frac{1}{b}+{\sum }_{s = t-{t}_{1}+1}^{t}{\sum }_{\tau = 1}^{s}{g}_{\tau }{M}_{s-\tau })}^{-1} $, respectively. Then the estimated value of $ {R}_{t} $ is set to be the median of the posterior distribution and the 0.025 and 0.975 quantiles are used to calculate the 95% confidence intervals.
By fitting the stochastic discrete model (2) to the epidemic data in Guangzhou from 21 May to 20 June 2021, we obtain the estimated values of unknown parameters listed in Table 1. The fitting results are shown in Figure 3, revealing that the fitted model captures the data well, in which the black circles are the daily case data reported (Figure 3(a)), the traced data of newly quarantined cases (Figure 3(b)), the cumulative case data reported (Figure 3(c)), the pink curves are the simulation results with the estimated parameters each time and the red curves are the mean results with the estimated parameters for 200 simulations.
Then by using the next generation matrix performed on the corresponding continuous model (1), we get the basic reproduction number as
$ {R}_{0} = \frac{(1-{q}_{1}){c}_{1}{\beta }_{1}}{{\delta }_{I}+{\gamma }_{I}}, $ |
which is estimated as $ {R}_{0} = 2.8359 $, consistent with the result in [8].
The estimation results show that $ {c}_{1} $ is much greater than $ {c}_{2} $, while the values of $ {\beta }_{1} $ and $ {\beta }_{2} $ are only a little different, which means that the home quarantining contributes to reducing the contact rate greatly. $ {q}_{1} $ is much less than $ {q}_{2} $, meaning that the contact tracing and centralized quarantine rates for home quarantined individuals is much greater, and that the home quarantining increases the accuracy of the contact tracing. The proportion of infected individuals move into home quarantine (i.e., $ {p}_{E} $ and $ {p}_{I} $) are close to 1, which means that the majority of infected cases (including exposed cases and infectious cases) are home quarantined, which is consistent with the fact that almost all reported cases were in the closed management areas [33].
By estimating the exponential growth rate of the newly reported cases in the early stage of the epidemic, we obtain that the exponential growth rate is 0.4044 per day and the basic reproduction number is calculated as 4.2025 in the epidemic in Guangzhou 2020, and the exponential growth rate is 0.3508 per day and the basic reproduction number is calculated as 2.3259 in 2021, which is in the 95% CI in [8]. The exponential growth curves and the effective reproduction numbers in 2020 and 2021 are shown in Figure 4. The results show that the basic reproduction number of Guangzhou in 2021 is much lower than that in 2020, which is not consistent with the fact that the Delta variant is much more transmissible than the original strain, and the basic reproduction number is 2.1-2.85 times greater [12,37]. This is mainly attributable to the implementation of the normalized control interventions and the actively promoted vaccination program in 2021, which also indicates that the vaccine against COVID-19 is useful for protecting the city from a higher transmission risk. Thus, it is important to maintain the NPIs and promote the vaccination program.
Based on the above estimated results, we focus on the effectiveness of the centralized quarantine and the home quarantine on the epidemic containment in Guangzhou in 2021. Therefore, through numerical analysis, we will analyze the impact of the timing $ T $ of the implementation of the compulsory home quarantine measure, the diagnosis rate $ {\delta }_{{I}_{h}} $ for home quarantined individuals, the centralized quarantine rate $ {q}_{1} $ for unquarantined individuals, the centralized quarantine rate $ {q}_{2} $ for home quarantined individuals, on the final size and the end time of the epidemic.
First of all, we conduct a sensitivity analysis to show what would happen if the compulsory home quarantine measure was implemented in advance or later, as shown in Figure 5 and Table 2. The results show that, if the compulsory home quarantine measure was implemented ahead of time, both the newly reported cases and the newly quarantined cases would be greatly decreased (Figure 5) and the end time of the epidemic would be significantly brought forward. The numbers of reported cases diagnosed from the unquarantined, the centralized quarantined and the home quarantined individuals all decrease. In particular, if $ T = 5 $ or $ T = 3 $, namely, the compulsory home quarantine measure was implemented 3 days or 5 days ahead of time (on 24 or 26 May), the number of reported cases from unquarantined, the centralized quarantined and the home quarantined individuals would be 6, 31, 23 or 3, 16, 12, respectively (see Table 2), being reduced by 57.14%, 63.1%, 58.93% or 78.57%, 80.95%, 78.57%, respectively. The final size would be reduced by 61.04% or 79.87% (reduced from 154 cases to 60 cases or to 31 cases), and the period of the epidemic would be shortened by 9 or 13 days (the end time would be brought forward from 18 to 10 or 5 June). Delaying the implementation timing of the compulsory home quarantine measure would lead to a more severe epidemic, with more reported cases and longer epidemic length. The numbers of reported cases diagnosed from the unquarantined, the centralized quarantined and the home quarantined individuals would all increase. In particular, if $ T = 9 $ or $ T = 11 $, namely, the compulsory home quarantine measure was implemented 1 day or 3 days later (on 30 May or 1 June), the number of reported cases from the unquarantined, the centralized quarantined and the home quarantined individuals would be 19, 117, 77 or 30, 191, 123, respectively (see Table 2), being increased by 35.71, 39.29, 37.5% or 114.29, 127.38, 119.64%, respectively. The final size would be increased by 38.31% or 123.38% (increased from 154 to 213 or to 344 cases), the epidemic would be lengthened by 3 or 8 days (the end time would be postponed from 18 to 21 or 26 June. In Table 2, the final size and the end time of the epidemic varying with respect to different implementation timings of the compulsory home quarantine measure are summarized.
The parameter $ {\delta }_{{I}_{h}} $ reflects the screening rate of the home quarantined individuals, and the quarantine rate $ {q}_{2} $ from home quarantine to centralized quarantine reflects the contact tracing accuracy of the home quarantined individuals. In order to further investigate the impact of $ {\delta }_{{I}_{h}} $ and $ {q}_{2} $ on the final size and the end time of the epidemic in Guangzhou, with different implementation timings $ T $ of the compulsory home quarantine measure, we illustrate the relationships with contour plots of the final size and the length of the epidemic with respect to $ T $ and $ {\delta }_{{I}_{h}} $, $ T $ and $ {q}_{2} $, respectively (Figures 6 and 7). The results indicate that the final size and the length of the epidemic both decrease with the decreasing of $ T $ and increasing of $ {\delta }_{{I}_{h}} $ and $ {q}_{2} $, meaning that despite early implementation of the compulsory home quarantine measure, strengthening the screening and the contact tracing intervention of the home quarantined individuals can also help to control the epidemic. However, it follows from Figure 6 (a), (b) that if the value of $ {\delta }_{{I}_{h}} $ is small enough, for example, $ {\delta }_{{I}_{h}} = 0.08 $, the final size would exceed 500 and the epidemic would last over 50 days, which are both far more than the actual situation with 154 cases and 29 days, regardless of the value of $ T $. This means that the effectiveness of the early implementation of the compulsory home quarantine measure would be wasted if the home quarantine population were not sufficiently screened and tested. Another important point is that delaying the implementation timing leads to a severer epidemic than the actual situation even with stricter screening and testing intervention (larger $ {\delta }_{{I}_{h}} $), for example, when $ T = 10 $, the final size would be no less than 200 and the duration of the epidemic would be no shorter than 30 days, regardless of the value of $ {\delta }_{{I}_{h}} $. Similar results can be obtained for $ {q}_{2} $ and $ T $ from Figure 7 (a) and (b). What is worse, if the quarantine rate $ {q}_{2} $ is decreased to the quarantine rate $ {q}_{1} $ ($ {q}_{2} = {q}_{1} = 0.1719 $), the epidemic would last more than 100 days and the final size would be almost 500 cases, much severer than the actual situation. The results demonstrate the importance of enhancing the screening and the contact tracing interventions for individuals home quarantined, as well as the early implementation of the compulsory home quarantine policy.
$ T $ | Reported cases from the unquarantined population | Reported cases from the centralized quarantined population | Reported cases from the home quarantined population | Reported cases in total | Duration of the epidemic (days) |
|||
Count | Proportion | Count | Proportion | Count | Proportion | |||
1 | 1 | 5.26% | 10 | 52.63% | 8 | 42.11% | 19 | 11 (to 31 May) |
2 | 2 | 8.7% | 12 | 52.17% | 9 | 39.13% | 23 | 14 (to 3 June) |
3 | 3 | 9.68% | 16 | 51.61% | 12 | 38.71% | 31 | 16 (to 5 June) |
4 | 4 | 9.52% | 22 | 52.38% | 16 | 38.1% | 42 | 19 (to 8 June) |
5 | 6 | 10% | 31 | 51.67% | 23 | 38.33% | 60 | 21 (to 10 June) |
6 | 8 | 10% | 42 | 52.5% | 30 | 37.5% | 80 | 25 (to 14 June) |
7 | 10 | 9.26% | 58 | 53.7% | 40 | 37.04% | 108 | 27 (to 16 June) |
8 | 14 | 9.09% | 84 | 54.55% | 56 | 36.36% | 154 | 29 (to 18 June) |
9 | 19 | 8.92% | 117 | 54.93% | 77 | 36.15% | 213 | 32 (to 21 June) |
10 | 24 | 8.57% | 155 | 55.36% | 101 | 36.07% | 280 | 34 (to 23 June) |
11 | 30 | 8.72% | 191 | 55.52% | 123 | 35.76% | 344 | 37 (to 26 June) |
12 | 41 | 8.47% | 270 | 55.79% | 173 | 35.74% | 484 | 39 (to 28 June) |
To further investigate the combined effect of the centralized quarantine and home quarantine on the epidemic in Guangzhou in 2021, especially the impact of the quarantine rate $ {q}_{1} $ for unquarantined individuals, the quarantine rate $ {q}_{2} $ for home quarantined individuals, and the implementation timing $ T $ of the compulsory home quarantine measure, counter plots of the final size and the duration of the epidemic with respect to $ {q}_{1} $ and $ T $, $ {q}_{1} $ and $ {q}_{2} $, are conducted respectively (Figures 8 and 9). It follows from Figure 8 that increasing $ {q}_{1} $ would greatly decrease the final size and significantly shorten the duration of the epidemic. Furthermore, with a quarantine rate $ {q}_{1} $ greater than 0.5, though increasing $ T $ would increase the final size and lengthen the duration of the epidemic, the epidemic can be eliminated in 25 days with less than 100 reported cases in total, regardless of the value of $ T $. In particular, by fixing the implementation timing $ T = 8 $, increasing $ {q}_{1} $ to the level of $ {q}_{2} $, which is the quarantine rate for those home quarantined, i.e., $ {q}_{1} = {q}_{2} = 0.9277 $, the epidemic in Guangzhou would be eliminated in 2 weeks and the final size would be less than 30, illustrating the importance of enhancing the contact tracing intensity in the initial stage of the epidemic. Figure 9 shows that given the implementation timing $ T = 8 $ of the compulsory home quarantine measure, if the quarantine rate $ {q}_{1} $ is large enough, for example, $ {q}_{1} = 0.8 $, then increasing the quarantine rate $ {q}_{2} $ would have a slight impact on controlling the epidemic. However, if $ {q}_{1} $ is not large enough, then increasing $ {q}_{2} $ to exceed a critical level would be useful to control the epidemic. Both contour plots illustrate the high efficiency of the contact tracing and centralized quarantine intervention in the early stages of the epidemic.
Several outbreaks of COVID-19 have occurred in China after the successful control of the outbreak in early 2020. One of the main reasons for the resurgence is imported cases from high-risk regions and the introduction of more transmissible variants. Since it is still impossible to develop a long-term effective vaccine against the new coronavirus, exploring an efficient and useful epidemic prevention model plays an important role in the healthy development of the entire human society. In China, despite the actively promoted vaccination program, there are three main strategies implemented by the government: the precise control strategy including the contact tracing and centralized quarantine, screening and testing of the close contacts; the key group-based control strategy, such as home quarantine; and the whole population-based control strategy, for example, large-scale nucleic acid screening and testing.
In this paper, we proposed a discrete stochastic model based on the transmission progression of the COVID-19 epidemic in Guangzhou from 21 May 2021 caused by the Delta variant, and the prevention and control policy, which described the combined strategies of centralized quarantine by close contact tracing and the compulsory home quarantine measures, to investigate the efficiency of the combined strategies. The proposed model was calibrated by using the data of the COVID-19 epidemic in 2021 in Guangzhou city from 21 May to 20 June (Figure 3). The estimation showed that the centralized quarantine rate for home quarantined individuals was much greater than that for unquarantined individuals, indicating that the home quarantine measure contributed to increasing the contact tracing accuracy.
It has been well known that the Delta variant of SARS-CoV-2 is 97% more transmissible than the original strain, and the basic reproduction number is 2.1-2.85 times greater [12,37]. However, the comparison of the epidemic in 2020 with the epidemic in 2021 in Guangzhou showed that the exponential growth rate of the number of newly infected cases in 2021 was smaller than that in 2020, and the basic reproduction number in 2021 was lower than that in 2020 (Figure 4), which indicated that the normalized control interventions and the vaccination program have played an important role in the control and prevention of the COVID-19 epidemic in 2021 in Guangzhou. Hence, it is vital to maintain the implementation of normalized control interventions and actively promote the vaccination program to avoid the transmission of the variants with high transmission ability.
We investigated how the final size and the duration of the epidemic change with respect to different parameters, including the implementation timing $ T $ of the compulsory home quarantine, the diagnosis rate $ {\delta }_{{I}_{h}} $, the centralized quarantine rate $ {q}_{2} $ for home quarantined individuals, the centralized quarantine rate $ {q}_{1} $ for unquarantined individuals. Sensitivity analysis showed that the earlier that the compulsory home quarantine policy was issued, the quicker the epidemic would be eliminated and the lower the final size (Figure 5 and Table 2). The results showed that 94 infections would be avoided if the compulsory home quarantine measure was implemented 3 days earlier and 190 infections would be increased if the compulsory home quarantine measure was implemented 3 days later.
We observed from Figures 6 and 7 that bringing forward the implementation timing only was not enough, as enhancing the screening and testing intervention and increasing the accuracy of close contact tracing for individuals were also important. Even if the compulsory home quarantine measure was carried out on the first day, there would be a severer outbreak if the screening or contact tracing for home quarantined individuals was weakly implemented. Figures 8 and 9 told us that despite the timely implementation of the compulsory home quarantine measure, the strict centralized quarantine measure by close contact tracing for home quarantined population, the centralized quarantine measure in the initial stage of the epidemic (before the implementation of home quarantine measure) played an important role in curbing the epidemic transmission. The results showed that a sufficiently implemented contact tracing and centralized quarantine strategy for unquarantined population in the initial stage would contain the epidemic faster with less infections, even with weakly implemented compulsory home quarantine measure. However, if the contact tracing intensity was insufficient, then early implementation of the compulsory home quarantine measure and enhancing the screening of testing for home quarantined individuals indeed would prevent a large outbreak. The contact tracing intensity could be further enhanced if automatic tracing using an application on mobile telephones was introduced, as one has been shown to curb the spread of COVID-19 in the United Kingdom [38].
We have to point out that, several districts with a total population 470, 750 were adjusted to closed management areas successively from 29 May 2021 [15], the compulsory home quarantine measure was implemented gradually in these areas other than on the specific day, the population that were home quarantined varied per day, thus it may be more reasonable to incorporate time varying proportions of unquarantined susceptible, exposed, infected individuals becoming home quarantined susceptible, exposed, infected individuals, respectively. Further, we focused on the situation in Guangzhou and did not consider the cost of the centralized quarantine measure, the compulsory home quarantine measure. However, both of these two quarantine strategies require high expenditure, thus how to balance the expense, on the basis of the principle that the fewer the number of reported cases as possible, the better, would be interesting and important in countries with limited resources. These all fall in the scope of our further work.
The epidemic in Guangzhou in 2021, together with several other recent outbreaks in Nanjing and Zhengzhou in China, revealed that the emerging variants with higher transmission ability are a major concern when designing measures to prevent the resurgence of COVID-19 in China. An overall control strategy combining the precise control strategy, the key group-based strategy and the whole population-based control strategy should be maintained even with a mass vaccination program. Furthermore, more attention should be paid to the precise control strategy once a positive case is reported, and the key group-based control measure should be strictly implemented if the initial precise control strategy is not put into effect with sufficient rigour.
The authors are supported by the National Natural Science Foundation of China (grant numbers: 12031010(ST), 12001349(WZ), 12126350(ST)) and the Postdoctoral Research Foundation of China (grant number: 2019M663611 (WZ)).
The authors declare there is no conflict of interest.
[1] |
Eckburg PB, Bik EM, Bernstein CN, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638. doi: 10.1126/science.1110591
![]() |
[2] |
Qin J, Li R, Raes J, et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65. doi: 10.1038/nature08821
![]() |
[3] |
Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214. doi: 10.1038/nature11234
![]() |
[4] |
Corthier G, Dore J (2010) A new era in gut research concerning interactions between microbiota in human health. Gastroenterologie Clinique Biologique 34: S1-S6. doi: 10.1016/S0399-8320(10)70014-2
![]() |
[5] |
Flint HJ, Scott KP, Louis O, et al. (2012) The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9: 577-589. doi: 10.1038/nrgastro.2012.156
![]() |
[6] |
Attene-Ramos MS, Wagner ED, Plewa MJ, et al. (2006) Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 4: 9-14. doi: 10.1158/1541-7786.MCR-05-0126
![]() |
[7] |
Nyangale EP, Mottram DS, Gibson GR (2012) Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 11: 5573-5585. doi: 10.1021/pr300637d
![]() |
[8] |
Cerf-Bensussan N, Gaboriau-Routhiau V (2010) The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10: 735-744. doi: 10.1038/nri2850
![]() |
[9] |
Sommer F, Backhed F (2013) The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 11: 227-238 doi: 10.1038/nrmicro2974
![]() |
[10] |
Clemente JC, Ursell LK, Parfrey LW, et al. (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258-1270. doi: 10.1016/j.cell.2012.01.035
![]() |
[11] |
Aguirre M, Venema K (2015) The art of targeting gut microbiota for tackling human obesity. Genes Nutr 10: 20. doi: 10.1007/s12263-015-0472-4
![]() |
[12] |
Hold GL, Smith M, Grange C, et al. (2014) Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J Gastroenterol 20: 1192-1210. doi: 10.3748/wjg.v20.i5.1192
![]() |
[13] |
Wang Z, Klipfell E, Bennett B, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-65. doi: 10.1038/nature09922
![]() |
[14] |
Brusca SB, Abramson SB, Scher JU (2014) Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 26: 101-107. doi: 10.1097/BOR.0000000000000008
![]() |
[15] | Gao Z, Guo B, Gao R, et al. (2015) Microbiota dysbiosis is associated with colorectal cancer. Front Microbiol 6:20. |
[16] | Mima K, Nishihara R, Qian ZR, et al. (2015) Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. pii: gutjnl-2015-310101. doi: 10.1136/gutjnl-2015-310101. |
[17] | Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 125: 1401-1412. |
[18] |
Koenig JE, Spor A, Scalfone N, et al. (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108: 4578-4585. doi: 10.1073/pnas.1000081107
![]() |
[19] |
Albenberg LG, Wu GD (2014) Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 146: 1564-1572. doi: 10.1053/j.gastro.2014.01.058
![]() |
[20] |
De Filipo C, Cavalieri D, Di Paola M, et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Nattl Acad Sci U S A 107: 14691-14696. doi: 10.1073/pnas.1005963107
![]() |
[21] | David LA, Maurice CF, Carmody RN, et al. (2014) Diet rapidly and reproducibly alters the gut microbiome. Nature 505: 559-566. |
[22] |
Wu GD, Chen J, Hoffmann C, et al. (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-108. doi: 10.1126/science.1208344
![]() |
[23] |
Simpson HL, Cambell BJ (2015) Review article: Dietary fibre-microbiota interactions. Aliment Pharmocol Ther 42: 158-179. doi: 10.1111/apt.13248
![]() |
[24] |
Walker AW, Ince J, Duncam SH, et al. (2011) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5: 220-230. doi: 10.1038/ismej.2010.118
![]() |
[25] | Bouhnik Y, Raskine L, Vicaut E, et al. (2004) The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans. A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80: 1658-1664. |
[26] |
Saito Y, Hamanaka Y, Saito K, et al. (2002) Stability of species composition of fecal bifidobacteria in human subjects during fermented milk administration. Curr Microbiol 44:368-373. doi: 10.1007/s00284-001-0012-x
![]() |
[27] |
Muegge BD, Kuczynski J, Knights D, et al. (2011) Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332: 970-974. doi: 10.1126/science.1198719
![]() |
[28] |
Sonnenburg ED, Sonnenburg JL (2014) Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab 20: 779-786. doi: 10.1016/j.cmet.2014.07.003
![]() |
[29] | Roberfroid M, Gibson GR, Hoyles L, et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104: S1-S63. |
[30] | Gibson GR (2004) From probiotics to prebiotics and a healthy digestive system. J Food Sci 69: 141-143. |
[31] | Gibson GR, Scott KP, Rastall RA, et al. (2010) Dietary prebiotics: current status and new definition. Food Sci Technol Bull 7: 1-19. |
[32] |
Bindels LB, Delzenne NM, Cani PD, et al. (2015) Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 12: 303-310. doi: 10.1038/nrgastro.2015.47
![]() |
[33] |
Guarner F, Khan AG, Garish J, et al. (2012) World Gastroenterology Organization Global Guidelines Probiotics and prebiotics. J Clin Gastroenterol 46: 468-481. doi: 10.1097/MCG.0b013e3182549092
![]() |
[34] |
Bindels LB, Porporato P, Dewulf EM, et al. (2012) Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer 107: 1337-1344. doi: 10.1038/bjc.2012.409
![]() |
[35] | Clemente A (2014) In vivo assessment of the bioactivity of food oligosaccharides. In: Moreno FJ, Sanz ML, editors. Wiley Blackwell, Food oligosaccharides: production, analysis and bioactivity; pp 238-254. |
[36] |
Charalampopoulos D, Rastall RA (2012) Prebiotics in foods. Curr Opin Biotechnol 23: 187-191. doi: 10.1016/j.copbio.2011.12.028
![]() |
[37] | Corzo N, Alonso JL, Azpiroz F, et al. (2015) Prebiotics: concept, properties and beneficial effects. Nutr Hosp 31: 99-118. |
[38] |
Rastall RA (2010) Functional oligosaccharides: application and manufacture. Annu Rev Food Sci Technol 1: 305-339. doi: 10.1146/annurev.food.080708.100746
![]() |
[39] |
Vijn I, Smeekens S (1999) Fructan: more than a reserve carbohydrate? Plant Physiol 120: 351-60. doi: 10.1104/pp.120.2.351
![]() |
[40] |
Comparot-Moss S, Denyer K (2009) The evolution of the starch biosynthetic pathway in cereals and other grasses. J Exp Bot 60: 2481-2492. doi: 10.1093/jxb/erp141
![]() |
[41] |
Gallardo K, Thompson R, Burstin J (2008) Reserve accumulation in legume seeds. C R Biol 331: 755-762. doi: 10.1016/j.crvi.2008.07.017
![]() |
[42] |
Bahaji A, Li J, Sánchez-López ÁM, et al. (2014) Starch biosynthesis, its regulation and biotechnological approaches to improve crop yields. Biotechnol Adv 32: 87-106. doi: 10.1016/j.biotechadv.2013.06.006
![]() |
[43] |
Ao Z, Simsek S, Zhang G, et al. (2007) Starch with a slow digestion property produced by altering its chain length, branch density, and crystalline structure. J Agric Food Chem 55: 4540-45547. doi: 10.1021/jf063123x
![]() |
[44] | Galand G (1989) Brush border membrane sucrase-isomaltase, maltase-glucoamylase and trehalase in mammals. Comparative development, effects of glucocorticoids, molecular mechanisms, and phylogenetic implications. Comp Biochem Physiol B 94: 1-11. |
[45] |
Cairns AJ (2003) Fructan biosynthesis in transgenic plants. J Exp Bot 54: 549-567. doi: 10.1093/jxb/erg056
![]() |
[46] |
Hernandez-Hernandez O, Marín-Manzano MC, Rubio L, et al. (2012). Monomer and linkage type of galacto-oligosaccharides affect their resistance to ileal digestion and prebiotic properties in rats. J Nutr 142: 1232-1239. doi: 10.3945/jn.111.155762
![]() |
[47] |
Chi ZM, Zhang T, Cao TS, et al. (2011). Biotechnological potential of inulin for bioprocesses. Bioresour Technol 102: 4295-4303. doi: 10.1016/j.biortech.2010.12.086
![]() |
[48] |
Ernst MK, Chatterton NJ, Harrison PA, et al. (1998) Characterization of fructan oligomers from species of the genus Allium L. J Plant Physiol 153: 53-60. doi: 10.1016/S0176-1617(98)80044-8
![]() |
[49] | Roberfroid MB, Van Loo JAE, Gibson GR (1998) The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutrition 128: 11-19. |
[50] |
Yun JW (1996) Fructooligosaccharides—occurrence, preparation, and application. Enzyme Microbial Technol 19: 107-117. doi: 10.1016/0141-0229(95)00188-3
![]() |
[51] | Macfarlane GT, Steed H, Macfarlane S (2008) Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104: 305-344. |
[52] |
Al-Tamimi MAHM, Palframan RJ, Cooper JM, et al. (2006) In vitro fermentation of sugar beet arabinan and arabinooligosaccharides by the human gut microflora. J Appl Microbiol 100: 407-414. doi: 10.1111/j.1365-2672.2005.02780.x
![]() |
[53] | Hotchkiss AT, Nunez A, Rastall RA, et al. (2010) Growth promotion of beneficial bacteria in gut of human comprises administering composition comprising arabino oligosaccharide as prebiotic. U.S. patent 2010316766-A1. |
[54] | Gómez B, Miguez B, Veiga A, et al. (2015) Production, purification and in vitro evaluation of the prebiotic potential of arabinoxylooligosaccharides from breweŕs spent grain. J Agric Food Chem [In press]. |
[55] |
Palframan RJ, Gibson GR, Rastall RA (2002) Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerobe 8: 287-292. doi: 10.1006/anae.2002.0434
![]() |
[56] |
Rycroft CE, Jones MR, Gibson GR, et al. (2001) A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91: 878-887. doi: 10.1046/j.1365-2672.2001.01446.x
![]() |
[57] |
Sanz ML, Gibson GR, Rastall RA (2005) Influence of disaccharide structure on prebiotic selectivity in vitro. J Agric Food Chem 53: 5192-5199. doi: 10.1021/jf050276w
![]() |
[58] |
Sulek K, Vigsnaes LK, Schmidt LR, et al. (2014) A combined metabolomic and phylogenetic study reveals putatively prebiotic effects of high molecular weight arabino-oligosaccharides when assessed by in vitro fermentation in bacterial communities derived from humans. Anaerobe 28: 68-77. doi: 10.1016/j.anaerobe.2014.05.007
![]() |
[59] |
Westphal Y1, Kühnel S, de Waard P, et al. (2010) Branched arabino-oligosaccharides isolated from sugar beet arabinan. Carbohydr Res 345: 1180-1189. doi: 10.1016/j.carres.2010.03.042
![]() |
[60] |
Thomassen LV, Vigsnaes LK, Licht TR, et al. (2011) Maximal release of highly bifidogenic soluble dietary fibers from industrial potato pulp by minimal enzymatic treatment. Appl Microbiol Biotechnol 90: 873-884. doi: 10.1007/s00253-011-3092-y
![]() |
[61] |
Vigsnæs LK, Holck J, Meyer AS, et al. (2011) In Vitro Fermentation of Sugar Beet Arabino-Oligosaccharides by Fecal Microbiota Obtained from Patients with Ulcerative Colitis To Selectively Stimulate the Growth of Bifidobacterium spp. and Lactobacillus spp. Appl Env Microbiol 77: 8336-8344. doi: 10.1128/AEM.05895-11
![]() |
[62] |
Chung Y, Hsu C, Ko C, et al. (2007). Dietary intake of xylooligosaccharides improves the intestinal microbiota, fecal Moisture, and pH Value in the elderly. Nutr Res 27: 756-761. doi: 10.1016/j.nutres.2007.09.014
![]() |
[63] |
Lecerf JM, Depeint F, Clerc E, et al. (2012) Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 108: 1847-1858. doi: 10.1017/S0007114511007252
![]() |
[64] |
Sheu WHH, Lee IT, Chen W, et al. (2008) Effects of xylooligosaccharides in type 2 diabetes mellitus. J Nutr Sci Vitaminol 54: 396-401. doi: 10.3177/jnsv.54.396
![]() |
[65] | Koga Y, Shibuta T, O'Brien R (1993) Soybean oligosaccharides. In Oligosaccharides. Production, properties and applications. Japan. Technol. Rev. Section E: Biotechnology vol. 3, No 2. Nakakuki T Ed; Gordon and Breach Science Publishers: Switzerland, pp. 175-203 |
[66] |
Li T, Lu X, Yang X (2013) Stachyose-enriched α-galacto-oligosaccharides regulate gut microbiota and relieve constipation in mice. J Agric Food Chem 61: 11825-11831. doi: 10.1021/jf404160e
![]() |
[67] |
Ao Z, Quezada-Calvillo R, Sim L, et al. (2007) Evidence of native starch degradation with human small intestinal maltase-glucoamylase (recombinant). FEBS Lett 581: 2381-2388. doi: 10.1016/j.febslet.2007.04.035
![]() |
[68] | Cardelle-Cobas A, Olano A, Corzo N, et al. (2012) In vitro fermentation of lactulose-derived oligosaccharides by mixed fecal microbiota. J Agric Food Chem 60: 20124-2032. |
[69] |
Marín-Manzano MC, Abecia L, Hernandez-Hernandez O, et al. (2013) Galacto-oligosaccharides derived from lactulose exert a selective stimulation on the growth of Bifidobacterium animalis in the large intestine of growing rats. J Agric Food Chem 61: 7560-7567. doi: 10.1021/jf402218z
![]() |
[70] |
Georgi G, Bartke N, Wiens F, et al. (2013) Functional glycans and glycoconjugates in human milk. Am J Clin Nutr 98: 578S-85S. doi: 10.3945/ajcn.112.039065
![]() |
[71] |
Li M, Bauer LL, Chen X, et al. (2012). Microbial composition and in vitro fermentation patterns of human milk oligosaccharides and prebiotics differ between formula-fed and sow-reared piglets. J Nutr 142: 681-689. doi: 10.3945/jn.111.154427
![]() |
[72] |
Barile D, Rastall RA (2013) Human milk and related oligosaccharidesas prebiotics. Curr Opin Biotechnol 24: 214-219. doi: 10.1016/j.copbio.2013.01.008
![]() |
[73] |
Ruiz-Moyano S, Totten SM, Garrido DA, et al. (2013) Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl Environ Microbiol 79: 6040-6049. doi: 10.1128/AEM.01843-13
![]() |
[74] | Martin-Ortiz A, Barile D, Salcedo J, et al. (2015) Characterization of goat colostrum oligosaccharides by nano-liquid chromatography on chip quadrupole time of flight mass spectrometry and hydrophilic interaction liquid chromatography-quadrupole mass spectrometry. J Chrom A [in press]. |
[75] |
Lara-Villoslada F, Debras E, Nieto A, et al. (2006) Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr 25: 477-488. doi: 10.1016/j.clnu.2005.11.004
![]() |
[76] |
Padilla B, Frau F, Ruiz-Matute AI, et al. (2015). Production of lactulose oligosaccharides by isomerisation of transgalactosylated cheese whey permeate obtained by β-galactosidases from dairy Kluyveromyces. J Dairy Res 82: 356-364. doi: 10.1017/S0022029915000217
![]() |
[77] |
Panesar PS, Kumari S (2011) Lactulose: Production, purification and potential applications. Biotechnol Adv 29: 940-948. doi: 10.1016/j.biotechadv.2011.08.008
![]() |
[78] |
Olano A, Corzo N (2009) Lactulose as a food ingredient. J Sci Food Agric 89: 1987-1990. doi: 10.1002/jsfa.3694
![]() |
[79] | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) Scientific opinion on the substantiation of healthclaims related to lactulose and decreasing potentially pathogenicgastro-intestinal microorganisms (ID 806) and reductionin intestinal transit time (ID 807) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J 8: 1806-1821. |
[80] | Schumann C (2002) Medical, nutritional and technological properties of lactulose. An update. Eur J Nutr 41:17-25. |
[81] |
Foster KJ, Lin S, Turck CJ (2010) Current and emerging strategies for treating hepatic encephalopathy. Crit Care Nurs Clin North Am 22: 341-350. doi: 10.1016/j.ccell.2010.04.007
![]() |
[82] |
Sussman NL (2015) Treatment of Overt Hepatic Encephalopathy. Clin Liver Dis 19: 551-563. doi: 10.1016/j.cld.2015.04.005
![]() |
[83] | Kaneko T, Yokoyama A, Suzuki M (1995) Digestibility characteristics of isomalto-oligosaccharides in comparison with several saccharides using the rat jejunum loop method. Biosci Biotechnol Biochem 9: 1190-1194. |
[84] |
Hu Y, Ketabi A, Buchko A, et al. (2013) Metabolism of isomalto-oligosaccharides by Lactobacillus reuteri and bifidobacteria. Lett Appl Microbiol 57: 108-114. doi: 10.1111/lam.12076
![]() |
[85] |
Ketabi A, Dieleman LA, Gänzle MG (2011) Influence of isomalto-oligosaccharides on intestinal microbiota in rats. J Appl Microbiol 110: 1297-1306. doi: 10.1111/j.1365-2672.2011.04984.x
![]() |
[86] | Yen CH, Tseng YH, Kuo YW, et al. (2011) Long-term supplementation of isomalto-oligosaccharides improved colonic microflora profile, bowel function, and blood cholesterol levels in constipated elderly people-a placebo-controlled, diet-controlled trial. Nutrition 17: 445-450. |
[87] | Wang HF, Lim P-S, Kao MD, et al. (2011) Use of isomalto-oligosaccharide in the treatment of lipid profiles and constipation in hemodialysis patients. J Renal Nutr 11: 73-79. |
[88] | Mizubuchi H, Yajima T, Aoi N, et al. (2005) Isomalto-Oligosaccharides Polarize Th1-Like Responses in Intestinal and Systemic Immunity in Mice. J Nutr 20: 2857-2861. |
[89] |
Valette P, Pelenc V, Djouzi Z, et al. (1993) Bioavailability of new synthesised glucooligosaccharides in the intestinal tract of gnotobiotic rats. J Sci Food Agricult 62:121-127. doi: 10.1002/jsfa.2740620204
![]() |
[90] |
Chung CH, Day DF (2002) Glucooligosaccharides from Leuconostoc mesenteroides B-742 (ATCC 13146): a potential prebiotic. J Indus Microbiol Biotechnol 29: 196-199. doi: 10.1038/sj.jim.7000269
![]() |
[91] |
Sarbini SR, Kolida S, Gibson GR, et al. (2013) In vitro fermentation of commercial α-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Bri J Nutr 109: 1980-1989 doi: 10.1017/S0007114512004205
![]() |
[92] | Wichienchot S, Prasertsan P, Hongpattarakere T, et al. (2006) In vitro Fermentation of Mixed Linkage Glucooligosaccharides Produced by Gluconobacteroxydans NCIMB 4943 by the Human Colonic Microflora. Curr Issues Intestinal Microbiol 7: 7-12. |
[93] |
Gibson GR, Beatty ER, Wang X, et al. (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108: 975-982. doi: 10.1016/0016-5085(95)90192-2
![]() |
[94] |
Bouhnik Y, Achour L, Paineau D, et al. (2007) Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutrition 6: 42-46. doi: 10.1186/1475-2891-6-42
![]() |
[95] | Depeint F, Tzortzis G, Vulevic J, et al. (2008) Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 87: 785-791. |
[96] | Kleessen B, Sykura B, Zunft HJ, et al. (1997) Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 65: 1397-1402. |
[97] | Kruse HP, Kleessen B, Blaut M (1999) Effects of inulin on faecal bifidobacteria in human subjects. Br J Nutr 82: 375-382. |
[98] |
Ladirat SE, Schoterman MH, Rahaoui H, et al. (2014) Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment. Br J Nutr 112: 536-546. doi: 10.1017/S0007114514001135
![]() |
[99] |
Petry N, Egli I, Chassard C, et al. (2012) Inulin modifies the bifidobacteria population, fecal lactate concentration, and fecal pH but does not influence iron absorption in women with low iron status. Am J Clin Nutr 96: 325-331. doi: 10.3945/ajcn.112.035717
![]() |
[100] |
Tuohy KM, Kolida S, Lustenberger AM, et al. (2001) The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides - a human volunteer study. Br J Nutr 86: 341-348. doi: 10.1079/BJN2001394
![]() |
[101] |
Bäckhed F, Ding H, Wang T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718-15723. doi: 10.1073/pnas.0407076101
![]() |
[102] |
Tenbaum SP, Ordóñez-Morán P, Puig I, et al. (2012) β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 18: 892-901. doi: 10.1038/nm.2772
![]() |
[103] | Leenen CH, Dieleman LA (2007) Inulin and oligofructose in chronic inflammatory bowel disease. J Nutr 137: 2572S-2575S. |
[104] |
Puertollano E, Kolida S, Yaqoob P (2014) Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care 17: 139-144. doi: 10.1097/MCO.0000000000000025
![]() |
[105] |
Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23: 1097-1104. doi: 10.1111/j.1365-2036.2006.02854.x
![]() |
[106] |
Lindsay JO, Whelan K, Stagg AJ, et al. (2006) Clinical, microbiological and immunological effects of fructooligosaccharide in patients with Crohn's disease. Gut 55: 348-355. doi: 10.1136/gut.2005.074971
![]() |
[107] |
Candela M, Turroni S, Biagi E, et al. (2014) Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol 20: 908-922. doi: 10.3748/wjg.v20.i4.908
![]() |
[108] |
Silk DB, Davis A, Vulevic J, et al. (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29: 508-518. doi: 10.1111/j.1365-2036.2008.03911.x
![]() |
[109] |
Whelan K (2011) Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care 14: 581-587. doi: 10.1097/MCO.0b013e32834b8082
![]() |
[110] | Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol12: 661-672. |
[111] |
Scanlan PD, Shanahan F, Clune Y, et al. (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10: 789-798. doi: 10.1111/j.1462-2920.2007.01503.x
![]() |
[112] |
Marchesi JR, Dutilh BE, Hall N, et al. (2011) Towards the human colorectal cancer microbiome. PLoS One 6: e20447. doi: 10.1371/journal.pone.0020447. doi: 10.1371/journal.pone.0020447
![]() |
[113] |
Shen XJ, Rawls JF, Randall T, et al. (2010) Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 1: 138-147. doi: 10.4161/gmic.1.3.12360. doi: 10.4161/gmic.1.3.12360
![]() |
[114] |
Sobhani I, Tap J, Roudot-Thoraval F, et al. (2011) Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 6: e16393. doi: 10.1371/journal.pone.0016393
![]() |
[115] | Moore WE, Moore LH (1995) Intestinal floras of populations that have a high risk of colorectal cancer. Appl Environ Microbiol 61: 3202-3207. |
[116] |
Dewulf EM, Cani PD, Claus SP, et al. (2013) Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62: 1112-1121. doi: 10.1136/gutjnl-2012-303304
![]() |
[117] | Bosscher D, Breynaert A, Pieters L, et al. (2009). Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. J Physiol Pharmacol 60(Suppl 6):5-11. |
[118] | Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137: 2493S-2502S. |
[119] | Canfora EE, Jocken JW, Blaak EE (2015) Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11: 5775-5791. |
[120] | Hamer HM, Jonkers D, Venema K, et al. (2008). Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27: 104-119. |
[121] |
Wong JM, de Souza R, Kendall CW, et al. (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40: 235-243. doi: 10.1097/00004836-200603000-00015
![]() |
[122] |
Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63: 1513-1521 doi: 10.1136/gutjnl-2014-306928
![]() |
[123] |
Wagner NM, Brandhorst G, Czepluch F, et al. (2013) Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity Silver Spring 21: 461-468. doi: 10.1002/oby.20087
![]() |
[124] | Duncan SH, Aminov RI, Scott KP, et al. (2006) Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov., and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int J Syst Evol Micr 56: 2437-2441. |
[125] | Duncan SH, Hold GL, Harmsen HJM, et al. (2002) Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen nov., comb. nov. Int J Syst Evol Micr 52: 2141-2146. |
1. | Hao Wang, Weike Zhou, Xia Wang, Yanni Xiao, Sanyi Tang, Biao Tang, Modeling-based design of adaptive control strategy for the effective preparation of ‘Disease X’, 2025, 25, 1472-6947, 10.1186/s12911-025-02920-0 |
Variables | Description (Person) | Initial value | Resource |
mean (95%CI) | |||
$ S $ | Susceptible population unquarantined | 15, 300, 000 | [32] |
$ E $ | Exposed population unquarantined | 8.6602 (8.6358-8.6846) | Estimated |
$ I $ | Infectious population unquarantined | 3.9827 (3.9787-3.9867) | Estimated |
$ {S}_{q} $ | Centralized quarantined susceptible population | 0 | Data |
$ {E}_{q} $ | Centralized quarantined infected population | 0 | Data |
$ {S}_{h} $ | Home quarantined susceptible population | 0 | Data |
$ {E}_{h} $ | Home quarantined exposed population | 0 | Data |
$ {I}_{h} $ | Home quarantined infectious population | 0 | Data |
$ H $ | Hospitalized population | 0 | Data |
$ R $ | Recovered population | 0 | Data |
Parameters | Description | Value | Resource |
mean (95%CI) | |||
$ {c}_{1} $ | Contact rate among unquarantined population (per person per day) | 10.8614 (10.8348-10.8880) |
Estimated |
$ {\beta }_{1} $ | Transmission probability per contact among unquarantined population | 0.2538 (0.2523-0.2553) | Estimated |
$ {q}_{1} $ | Quarantine proportion of close contacts for individuals unquarantined | 0.1719 (0.1693-0.1744) | Estimated |
$ \sigma $ | Progression rate from exposed to infectious (per day) | 1/4.4 | [8,31] |
$ {\delta }_{I} $ | Diagnosis rate of infectious individuals unquarantined (per day) | 0.4633 (0.4604-0.4661) | Estimated |
$ {\gamma }_{I} $ | Recovery rate of unquarantined infectious individuals (per day) | 0.3417 (0.3275-0.3559) | Estimated |
$ {\lambda }_{1} $ | Releasing rate of susceptible individuals from centralized quarantine to home quarantine (per day) | 1/14 | [25,26] |
$ {\lambda }_{2} $ | Releasing rate of susceptible individuals from home quarantine (per day) | 1/14 | [25,26] |
$ {\delta }_{{E}_{q}} $ | Diagnosis rate of centralized quarantined infected individuals (per day) | 1/4.0745 | Data |
$ {c}_{2} $ | Contact rate among home quarantined population (per person per day) | 2.9966 (2.9947-2.9984) | Estimated |
$ {\beta }_{2} $ | Transmission probability per contact among home quarantined population | 0.2518 (0.2496-0.2540) | Estimated |
$ {q}_{2} $ | Quarantine proportion of close contacts for home quarantined individuals | 0.9277 (0.9254-0.9301) | Estimated |
$ {\delta }_{{I}_{h}} $ | Diagnosis rate of home quarantined infectious individuals (per day) | 0.5184 (0.5085-0.5284) | Estimated |
$ {\gamma }_{H} $ | Recovery rate of hospitalized individuals (per day) | 0.2640 (0.2563-0.2716) | Estimated |
$ {p}_{s} $ | Proportion of susceptible individuals being home quarantined | 0.0316 | Data |
$ {p}_{E} $ | Proportion of exposed individuals being home quarantined | 0.9995 (0.9994-0.9997) | Estimated |
$ {p}_{I} $ | Proportion of infectious individuals being home quarantined | 0.9844 (0.9834-0.9854) | Estimated |
$ T $ | Reported cases from the unquarantined population | Reported cases from the centralized quarantined population | Reported cases from the home quarantined population | Reported cases in total | Duration of the epidemic (days) |
|||
Count | Proportion | Count | Proportion | Count | Proportion | |||
1 | 1 | 5.26% | 10 | 52.63% | 8 | 42.11% | 19 | 11 (to 31 May) |
2 | 2 | 8.7% | 12 | 52.17% | 9 | 39.13% | 23 | 14 (to 3 June) |
3 | 3 | 9.68% | 16 | 51.61% | 12 | 38.71% | 31 | 16 (to 5 June) |
4 | 4 | 9.52% | 22 | 52.38% | 16 | 38.1% | 42 | 19 (to 8 June) |
5 | 6 | 10% | 31 | 51.67% | 23 | 38.33% | 60 | 21 (to 10 June) |
6 | 8 | 10% | 42 | 52.5% | 30 | 37.5% | 80 | 25 (to 14 June) |
7 | 10 | 9.26% | 58 | 53.7% | 40 | 37.04% | 108 | 27 (to 16 June) |
8 | 14 | 9.09% | 84 | 54.55% | 56 | 36.36% | 154 | 29 (to 18 June) |
9 | 19 | 8.92% | 117 | 54.93% | 77 | 36.15% | 213 | 32 (to 21 June) |
10 | 24 | 8.57% | 155 | 55.36% | 101 | 36.07% | 280 | 34 (to 23 June) |
11 | 30 | 8.72% | 191 | 55.52% | 123 | 35.76% | 344 | 37 (to 26 June) |
12 | 41 | 8.47% | 270 | 55.79% | 173 | 35.74% | 484 | 39 (to 28 June) |
Variables | Description (Person) | Initial value | Resource |
mean (95%CI) | |||
$ S $ | Susceptible population unquarantined | 15, 300, 000 | [32] |
$ E $ | Exposed population unquarantined | 8.6602 (8.6358-8.6846) | Estimated |
$ I $ | Infectious population unquarantined | 3.9827 (3.9787-3.9867) | Estimated |
$ {S}_{q} $ | Centralized quarantined susceptible population | 0 | Data |
$ {E}_{q} $ | Centralized quarantined infected population | 0 | Data |
$ {S}_{h} $ | Home quarantined susceptible population | 0 | Data |
$ {E}_{h} $ | Home quarantined exposed population | 0 | Data |
$ {I}_{h} $ | Home quarantined infectious population | 0 | Data |
$ H $ | Hospitalized population | 0 | Data |
$ R $ | Recovered population | 0 | Data |
Parameters | Description | Value | Resource |
mean (95%CI) | |||
$ {c}_{1} $ | Contact rate among unquarantined population (per person per day) | 10.8614 (10.8348-10.8880) |
Estimated |
$ {\beta }_{1} $ | Transmission probability per contact among unquarantined population | 0.2538 (0.2523-0.2553) | Estimated |
$ {q}_{1} $ | Quarantine proportion of close contacts for individuals unquarantined | 0.1719 (0.1693-0.1744) | Estimated |
$ \sigma $ | Progression rate from exposed to infectious (per day) | 1/4.4 | [8,31] |
$ {\delta }_{I} $ | Diagnosis rate of infectious individuals unquarantined (per day) | 0.4633 (0.4604-0.4661) | Estimated |
$ {\gamma }_{I} $ | Recovery rate of unquarantined infectious individuals (per day) | 0.3417 (0.3275-0.3559) | Estimated |
$ {\lambda }_{1} $ | Releasing rate of susceptible individuals from centralized quarantine to home quarantine (per day) | 1/14 | [25,26] |
$ {\lambda }_{2} $ | Releasing rate of susceptible individuals from home quarantine (per day) | 1/14 | [25,26] |
$ {\delta }_{{E}_{q}} $ | Diagnosis rate of centralized quarantined infected individuals (per day) | 1/4.0745 | Data |
$ {c}_{2} $ | Contact rate among home quarantined population (per person per day) | 2.9966 (2.9947-2.9984) | Estimated |
$ {\beta }_{2} $ | Transmission probability per contact among home quarantined population | 0.2518 (0.2496-0.2540) | Estimated |
$ {q}_{2} $ | Quarantine proportion of close contacts for home quarantined individuals | 0.9277 (0.9254-0.9301) | Estimated |
$ {\delta }_{{I}_{h}} $ | Diagnosis rate of home quarantined infectious individuals (per day) | 0.5184 (0.5085-0.5284) | Estimated |
$ {\gamma }_{H} $ | Recovery rate of hospitalized individuals (per day) | 0.2640 (0.2563-0.2716) | Estimated |
$ {p}_{s} $ | Proportion of susceptible individuals being home quarantined | 0.0316 | Data |
$ {p}_{E} $ | Proportion of exposed individuals being home quarantined | 0.9995 (0.9994-0.9997) | Estimated |
$ {p}_{I} $ | Proportion of infectious individuals being home quarantined | 0.9844 (0.9834-0.9854) | Estimated |
$ T $ | Reported cases from the unquarantined population | Reported cases from the centralized quarantined population | Reported cases from the home quarantined population | Reported cases in total | Duration of the epidemic (days) |
|||
Count | Proportion | Count | Proportion | Count | Proportion | |||
1 | 1 | 5.26% | 10 | 52.63% | 8 | 42.11% | 19 | 11 (to 31 May) |
2 | 2 | 8.7% | 12 | 52.17% | 9 | 39.13% | 23 | 14 (to 3 June) |
3 | 3 | 9.68% | 16 | 51.61% | 12 | 38.71% | 31 | 16 (to 5 June) |
4 | 4 | 9.52% | 22 | 52.38% | 16 | 38.1% | 42 | 19 (to 8 June) |
5 | 6 | 10% | 31 | 51.67% | 23 | 38.33% | 60 | 21 (to 10 June) |
6 | 8 | 10% | 42 | 52.5% | 30 | 37.5% | 80 | 25 (to 14 June) |
7 | 10 | 9.26% | 58 | 53.7% | 40 | 37.04% | 108 | 27 (to 16 June) |
8 | 14 | 9.09% | 84 | 54.55% | 56 | 36.36% | 154 | 29 (to 18 June) |
9 | 19 | 8.92% | 117 | 54.93% | 77 | 36.15% | 213 | 32 (to 21 June) |
10 | 24 | 8.57% | 155 | 55.36% | 101 | 36.07% | 280 | 34 (to 23 June) |
11 | 30 | 8.72% | 191 | 55.52% | 123 | 35.76% | 344 | 37 (to 26 June) |
12 | 41 | 8.47% | 270 | 55.79% | 173 | 35.74% | 484 | 39 (to 28 June) |